# Sarepta Raises Lower End of 2026 Revenue Guidance

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/50921
Published: 2026-11-07T16:06:41.000Z
Updated: 2026-11-07T16:06:41.000Z
Section: Business

> The revision applies to the company's full-year 2026 revenue outlook.

Sarepta Therapeutics raised the low end of its 2026 revenue guidance.

The revised outlook covers the full year.